Clinical trials
Completed Abdominal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Catholic University of the Sacred Heart | 2 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 2 |
| Asan Medical Center | 1 |
| Assiut University | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Mayo Clinic | 1 |
| Medical College of Wisconsin | 1 |
| Nanjing PLA General Hospital | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abdominal Neoplasms | 16 |
| Pelvic Neoplasms | 2 |
| Chylous Ascites | 1 |
| Colonic Neoplasms | 1 |
| Emergence Delirium | 1 |
| Epilepsy | 1 |
| Genital Diseases, Male | 1 |
| Genital Neoplasms, Female | 1 |
| Genital Neoplasms, Male | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.